- Home
- NRC vs BRBI Comparison
NRC vs BRBI Comparison
Compare NRC & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRC | BRBI |
|---|---|---|
| Founded | 1981 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.7M | 402.4M |
| IPO Year | 1997 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NRC | BRBI |
|---|---|---|
| Price | $21.12 | $14.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 100.6K | 2.0K |
| Earning Date | 10-27-2026 | 11-06-2026 |
| Dividend Yield | 3.03% | ★ 6.34% |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | $3.79 | N/A |
| Revenue Next Year | $8.35 | $17.58 |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $11.32 | $9.09 |
| 52 Week High | $23.68 | $16.61 |
Technical Indicators
Market Signals| Indicator | NRC | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 70.44 |
| Support Level | $19.65 | $14.42 |
| Resistance Level | $22.18 | $15.06 |
| Average True Range (ATR) | 0.73 | 0.17 |
| MACD | 0.07 | 0.46 |
| Stochastic Oscillator | 65.44 | 84.87 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered. However, the company divides it's operations into the following business lines: (1) investment banking and capital markets, (2) treasury sales & structuring, (3) investments and wealth management and (4) capital remuneration.